Rare diseases
Investigational molecules
Locations
A Study of Darovasertib Before Surgery or Radiation Therapy for Patients with Early-Stage Uveal Melanoma That Has Not Spread
The NetherlandsStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
The NetherlandsStudy of ruxolitinib cream for children aged 6 to 12 years with non-segmental vitiligo
The NetherlandsLong-term safety study of oral povorcitinib in patients with hidradenitis suppurativa, prurigo nodularis, or vitiligo who previously participated in clinical trials
The NetherlandsStudy of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease
The NetherlandsStudy of GSK5764227 alone and in combination for patients with previously treated advanced gastrointestinal tumors that cannot be removed by surgery or have spread
The NetherlandsStudy of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis
The NetherlandsStudy of Lutetium-177-DOTA-TATE with octreotide LAR in newly diagnosed patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NET) with high disease burden
The NetherlandsStudy of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease
The NetherlandsStudy of Ifinatamab Deruxtecan and Chemotherapy for Patients with Advanced or Metastatic Esophageal Squamous Cell Carcinoma
The NetherlandsStudy on the Safety and Effectiveness of Trastuzumab Deruxtecan vs. Palbociclib-Based Drug Combination for Advanced HR-Positive, HER2-Low Breast Cancer Patients
The NetherlandsStudy of RO7790121 (afimkibart) for Treatment and Long-term Management in Adults with Moderate to Severe Crohn's Disease
The NetherlandsTell us about your condition – we search every trial in Europe and connect you with the right site.
